Alterity Therapeutics Limited ATHE

$ 1.07 1.9%

Annual report 2022
added 08-31-2022

Alterity Therapeutics Limited Financial Statements 2011-2024 | ATHE

Annual Financial Statements Alterity Therapeutics Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	895 M	10.8 M	18.8 M	24.5 M	40.9 M	59.8 M	96.7 M	119 M	44 M	45.6 M
Shares	2.41 B	1.7 B	895 M	10.3 M	8.89 M	8.9 M	8.9 M	8.38 M	7.13 M	5.65 M	4.8 M	4.13 M
Historical Prices	0.58	0.85	1.6	0.6	1.61	2.67	2.19	3.6	6.66	67.9	12.7	10.7
Net Income	-12.8 M	-15.3 M	-13.5 M	-12.3 M	-8.27 M	-7.54 M	-7.73 M	-5.89 M	-13.3 M	-7.79 M	-5.24 M	-6.43 M
Revenue	-	-	-	109 K	201 K	132 K	143 K	177 K	364 K	151 K	2.53 M	163 K
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	177 K	8.21 M	4.49 M	2.53 M	163 K
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.28 K	1.3 K	3.88 K	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-17.3 M	-10.9 M	-9.64 M	-13.1 M	-16.5 M	-19.8 M	-11.9 M	-5.29 M	-6.24 M
Operating Expenses	-	-	-	-	-	-	-	16.7 M	28.1 M	16.4 M	7.83 M	6.44 M
General and Administrative Expenses	5.51 M	6.94 M	3.45 M	4.28 M	4.32 M	3.95 M	3.59 M	4.06 M	3.09 M	3.12 M	3.46 M	3.96 M

All numbers in AUD currency

Quarterly Income Statement Alterity Therapeutics Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency